Creganna Flexes its Micromuscles

The technology enables both controlled movement of a device and the active controlled release of substances from a device.The material requires low voltage, "only 1 or 2 volts" to activate, explained Magnus Krogh today at the MD&M West show in Anaheim. Krogh is in new technologies at the company.Devices made from Micromuscle can be formed into structures that move objects or made into a coating that releases drugs. The material enables miniaturization and works in a liquid environment.The technology was acquired by Creganna after the withdrawal of a significant Venture Capitalist forced the Swedish company, Micromuscle AB to seek voluntary liquidation. Creganna has retained technical personnel of Micromuscle to conduct a technology transfer and is engaged with former customers of Micromuscle to continue development projects incorporating the EAP technology."This bioactive polymer has 8 years of R&D to back it. We think it can be incorporated into existing and future devices," said Alan Crean director of business development. "OEMs telling us how they want to use the product and we are working with them to enable those advances."